Overview

A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

Status:
Completed

Trial end date:
2020-03-17

Target enrollment:

Participant gender:

Summary

A Randomized, Double-blinded, Multi-center, Phase III Study to Compare The Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 versus HCP1701 in Patients with Hypertension and Dyslipidemia

Phase:

Phase 3

Details

Lead Sponsor:

Hanmi Pharmaceutical Company Limited

Treatments:

Amlodipine
Ezetimibe
Losartan
Rosuvastatin Calcium